Haemonetics | HAE - Des Atouts





Des Atouts Changement Date
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Cerus USD 221.86M 6.67M 2025-12
Cooper Companies USD 12.48B 58.1M 2026-03
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
ICU Medical USD 3.97B 42.48M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.86B 144.34M 2026-06
Neogen USD 3.35B 13M 2026-03
OraSure Technologies USD 360.55M 18.62M 2026-06
Plus Therapeutics USD 19.92M 3.59M 2026-03
Quidel USD 5.72B 86.6M 2026-06
ResMed USD 8.97B 181.66M 2026-06
STAAR Surgical USD 451.12M 560K 2026-03
Steris USD 10.74B 1.1M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
US Physical Therapy USD 1.25B 6.82M 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06